L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 6:59 pm Sale | 2025-08-14 | 13G | APTEVO THERAPEUTICS INC PA APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 9,128 4.990% | -6,705 (-42.35%) | Filing |
| 2025-06-23 4:08 pm Purchase | 2025-06-18 | 13G | APTEVO THERAPEUTICS INC PA APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 15,833 9.950% | 14,722 (+1325.11%) | Filing |
| 2025-06-23 4:07 pm Sale | 2025-04-26 | 13G | APTEVO THERAPEUTICS INC PA APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 1,111 0.700% | -58 (-4.96%) | Filing |